gonorrhea Visby Medical Anticipates Rapid Uptake of Handheld PCR Test for STIs Premium The firm received clearance and CLIA waiver for a 30-minute point-of-care PCR assay for three common STIs earlier this week. Visby Medical Obtains FDA 510(k), CLIA Waiver for Multiplex STI Test Using Handheld PCR Device The CLIA waiver enables clinicians to run a 30-minute multiplex test for chlamydia, gonorrhea, and trichomonas during a patient's visit. JHU Researchers Develop 15-Minute PCR System, Drug-Resistant Gonorrhea Test Premium The Hopkins team expects to spinout a company soon in order to commercialize the technology in the next two to three years. CLIA Waiver in Hand, Binx Health Targeting Retailers, Urgent Care Centers With STI Tests Premium Binx Health said that when it received FDA CLIA waiver, it already had a strategic partner for sales of its POC platform and chlamydia and gonorrhea tests. CARB-X Commits up to $13.8M to Novel Microdevices for Point-of-Care STI Test Novel Microdevices is developing a portable, sample-to-answer instrument that is designed to perform molecular testing on untreated patient samples. Mar 30, 2021 Binx Health Chlamydia and Gonorrhea Test CLIA Waived Sep 9, 2020 Visby Medical Takes on STI, COVID-19 Testing With Single-Use PCR Machine Premium Aug 5, 2020 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition Jun 16, 2020 Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests Apr 30, 2020 FDA Provides Second Clearance for Binx MDx Platform Feb 11, 2020 New York State Approves Enzo Biochem STI Tests on GenFlex Platform Nov 19, 2019 Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA Nov 7, 2019 SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs Nov 4, 2019 Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service Premium Oct 15, 2019 Enzo Biochem Fiscal Q4 Revenues Down 8 Percent Sep 6, 2019 As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow Premium Aug 27, 2019 After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance Premium Aug 12, 2019 FDA Clears Binx Health Point-of-Care Testing Platform for Chlamydia, Gonorrhea Aug 5, 2019 SpeeDx Raises $15M in Equity Investment Jul 11, 2019 Enzo Biochem Gets NY Approval for Oral, Rectal CT/NG Test; Updates Lab Business Models May 24, 2019 Startup Novel Microdevices Developing Rapid Point-of-Care MDx System for STIs Premium May 23, 2019 FDA Clears Cepheid, Hologic CT/NG Assays for Extragenital Testing May 15, 2019 Binx Health Targeting Broader STI Screening With Rapid POC Platform Premium May 1, 2019 Binx Health Gets CE Mark for Chlamydia, Gonorrhea Point-of-Care Test Mar 19, 2019 Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays Load More Breaking News IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio' Polynesian Island Population History Revealed From Present-Day Human Genomes Aviv Scientific Closes $40M Series B Financing Round Roche Nabs CE Mark for Three Cobas Respiratory Test Panels Hexagon Bio Raises $61M in Private Financing Round GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing The Scan Not Yet a Permanent One NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials. Unfair Targeting Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases. Limited Rapid Testing The New York Times wonders why rapid tests for COVID-19 are not widely available in the US. Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.